An Animal Model of Hemophagocytic Lymphohistiocytosis
An Animal Model of Hemophagocytic Lymphohistiocytosis
批准号:
8099560
负责人:
Michael Jordan
金额:
$37.5万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-10 至 2013-06-30
关键词:
Activated LymphocyteAnimal ModelAntigen PresentationAntigensBirdsBloodBone MarrowBone Marrow CellsBone Marrow TransplantationBrainCD8B1 geneCaspaseCell physiologyCellsChildhoodDefectDendritic CellsDiseaseDisease modelEpstein-Barr Virus InfectionsFeverGenesGeneticHemophagocytic LymphohistiocytosesImmuneImmune responseInfectionInterferon Type IIInterferonsLeadLiverLymphocytic choriomeningitis virusMarrowModelingMusMutationNatural Killer CellsPancytopeniaPathogenesisPatientsPhenotypePopulationPopulation DynamicsProcessProductionRegulatory T-LymphocyteRelative (related person)RoleSeriesSplenomegalyStimulusSyndromeT-LymphocyteTestingViralViral AntigensVirusVirus Diseasesbasebonecell typecytotoxicimmune activationimmunoregulationimprovedin vivoinsightkillingsmacrophagemortalitynovelperforinresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hemophagocytic lymphohistiocytosis (HLH) is a childhood disorder of excessive and abnormal immune activation, characterized by severe damage to the bone marrow, and a mortality rate approaching 50%. Nearly all patients with HLH have a severe deficiency of cytotoxic killing by T and NK cells, and many of these patients have been found to harbor mutations in the gene encoding perforin. We developed a novel murine model of this disorder, in which perforin deficient (prf) mice are challenged with lymphocytic choriomeningitis virus (LCMV). Following infection, prf mice develop a phenotype that is nearly identical to HLH. Using this model, we have discovered that the HLH phenotype is directly driven by the abnormal overproduction of interferon gamma (IFN-g) by CD8+ T cells. Additionally, we have found that DC's from prf mice harbor increased amounts of viral antigen and acquire increased capacity to stimulate virus-specific T cells after infection. These findings implicate increased antigen presentation by DC populations as the underlying cause of IFN-g overproduction in prf mice, and suggest that perforin normally functions to down modulate antigen presentation. Multiple cell types that express perforin are known to interact with DC's. In order to identify which of these populations would normally down modulate stimulation by DC's, we have performed a series of cell depletion, transfer, and bone marrow transplantation experiments. These studies have revealed that perforin-expressing cell types can influence both DC function and in vivo IFN-g production, and suggest that CD8+ T cells are the most critical cell type exerting this regulatory effect. Based on our preliminary studies, we hypothesize that perforin-dependant cytotoxic killing of selected dendritic cells by CD8+ T cells limits the entry and/or persistence of antigen in DC populations, and thereby limits immune activation. To test our hypothesis, we will pursue the following specific aims: Aim 1.) Define how antigen handling and presentation differ between WT and prf DC subsets after LCMV infection. Aim 2.) Determine whether CD8+ T cells are the principle cell type that suppresses DC stimulatory function via a perforin-dependant mechanism. This project will lead to better understanding of how cytotoxic function regulates the immune response and lead to improved therapies for patients with HLH and perhaps many other immunopathologic disorders.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/pbc.24188
发表时间:
2013-01
期刊:
PEDIATRIC BLOOD & CANCER
影响因子:
3.2
作者:
[Marsh, Rebecca A., Allen, Carl E., McClain, Kenneth L., Weinstein, Joanna L., Kanter, Julie, Skiles, Jodi, Lee, Nadine D., Khan, Shakila P., Lawrence, Julia, Mo, Jun Q., Bleesing, Jack J., Filipovich, Alexandra H., Jordan, Michael B.]
通讯作者:
Jordan, Michael B.
DOI:
10.1002/stem.2040
发表时间:
2015-07
期刊:
Stem cells (Dayton, Ohio)
影响因子:
--
作者:
[McCabe A, Zhang Y, Thai V, Jones M, Jordan MB, MacNamara KC]
通讯作者:
MacNamara KC
DOI:
10.1111/j.1365-2141.2011.08785.x
发表时间:
2011-09
期刊:
British journal of haematology
影响因子:
6.5
作者:
[Marsh RA, Jordan MB, Filipovich AH]
通讯作者:
Filipovich AH
DOI:
10.4049/jimmunol.1201525
发表时间:
2012-10-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Borges M, Barreira-Silva P, Flórido M, Jordan MB, Correia-Neves M, Appelberg R]
通讯作者:
Appelberg R
Abatacept for the treatment of Common Variable Immunodeficiency with Interstitial Lung Disease (ABCVILD) IND #152820 9/2/20
-
批准号:10281394
-
项目类别:
-
资助金额:$81.53万
-
财政年份:2021
-
负责人:Michael Jordan
-
依托单位:
Redefining hemophagocytic lymphohistiocytosis in hematologic malignancies
-
批准号:10322756
-
项目类别:
-
资助金额:$21.85万
-
财政年份:2021
-
负责人:Michael Jordan
-
依托单位:
Abatacept for the treatment of Common Variable Immunodeficiency with Interstitial Lung Disease (ABCVILD) IND #152820 9/2/20
-
批准号:10485232
-
项目类别:
-
资助金额:$22.71万
-
财政年份:2021
-
负责人:Michael Jordan
-
依托单位:
Redefining hemophagocytic lymphohistiocytosis in hematologic malignancies
-
批准号:10112637
-
项目类别:
-
资助金额:$18.58万
-
财政年份:2021
-
负责人:Michael Jordan
-
依托单位:
Biomedical Big Data Training Program at UC Berkeley
-
批准号:9116693
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2016
-
负责人:Michael Jordan
-
依托单位:
Biomedical Big Data Training Program at UC Berkeley
-
批准号:9904743
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2016
-
负责人:Michael Jordan
-
依托单位:
Hybrid ImmunoTherapy (ATG/Dexamethasone/Etoposide) for Hemophagocytic Lymphohisti
-
批准号:8444429
-
项目类别:
-
资助金额:$21.85万
-
财政年份:2012
-
负责人:Michael Jordan
-
依托单位:
Hybrid ImmunoTherapy (ATG/Dexamethasone/Etoposide) for Hemophagocytic Lymphohisti
-
批准号:8242462
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2012
-
负责人:Michael Jordan
-
依托单位:
Hybrid ImmunoTherapy (ATG/Dexamethasone/Etoposide) for Hemophagocytic Lymphohisti
-
批准号:8607990
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2012
-
负责人:Michael Jordan
-
依托单位:
An Animal Model of Hemophagocytic Lymphohistiocytosis
-
批准号:7837337
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Michael Jordan
-
依托单位:
An Animal Model of Hemophagocytic Lymphohistiocytosis
-
批准号:7317499
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2007
-
负责人:Michael Jordan
-
依托单位:
An Animal Model of Hemophagocytic Lymphohistiocytosis
-
批准号:7896615
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2007
-
负责人:Michael Jordan
-
依托单位:
An Animal Model of Hemophagocytic Lymphohistiocytosis
-
批准号:7931533
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2007
-
负责人:Michael Jordan
-
依托单位:
An Animal Model of Hemophagocytic Lymphohistiocytosis
-
批准号:7633296
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2007
-
负责人:Michael Jordan
-
依托单位:
An Animal Model of Hemophagocytic Lymphohistiocytosis
-
批准号:7996717
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2007
-
负责人:Michael Jordan
-
依托单位:
B Cell Expansion After Dendritic Cell Immunization
-
批准号:6547247
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2002
-
负责人:Michael Jordan
-
依托单位:
B Cell Expansion After Dendritic Cell Immunization
-
批准号:6945114
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2002
-
负责人:Michael Jordan
-
依托单位:
B Cell Expansion After Dendritic Cell Immunization
-
批准号:6640399
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2002
-
负责人:Michael Jordan
-
依托单位:
海外基金